Celgene Corporation

At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.

Type
Public
HQ
Summit, US
Founded
1986
Size (employees)
7,132 (est)+3%
Celgene Corporation was founded in 1986 and is headquartered in Summit, US

Key People at Celgene Corporation

Mark Alles

Mark Alles

Chief Executive Officer
Robert Hugin

Robert Hugin

Executive Chairman
Jacqualyn Fouse

Jacqualyn Fouse

President and Chief Operating Officer
Peter Kellogg

Peter Kellogg

Executive Vice President and Chief Financial Officer

Celgene Corporation Office Locations

Celgene Corporation has offices in Summit, Singapore, Boudry
Summit, US
Singapore, SG
Boudry, CH

Celgene Corporation Metrics

Celgene Corporation Summary

Market capitalization

$92 B

Closing share price

$119
Celgene Corporation's current market capitalization is $92 B.

Celgene Corporation Financials

Celgene Corporation's revenue is $9.26 B in FY, 2015 which is a 20.67% increase from the previous period.
FY, 2015FY, 2014FY, 2013

Revenue

$9.26 B$7.67 B$6.49 B

Net Income

$1.6 B$2 B$1.45 B

Celgene Corporation Market Value History

Celgene Corporation Online Presence

Celgene Corporation Company Life

You may also be interested in